Join the club for FREE to access the whole archive and other member benefits.

Rohit Loomba

Director, NAFLD Research Center, and Director of Hepatology, University of California at San Diego

Rohit Loomba, MD, MHSc, is an expert in the clinical management of chronic liver diseases and holds a joint appointment in the Division of Gastroenterology in the Department of Medicine and the Division of Epidemiology in the Department of Family and Preventive Medicine, University of California at San Diego School of Medicine.

His research focuses on all aspects of nonalcoholic fatty liver disease including aging, epidemiology, genetic and environmental predisposition, natural history, and treatment of nonalcoholic steatohepatitis (NASH). 

He utilizes diverse epidemiologic and outcomes research methodologies to answer clinically relevant questions. The types of research conducted includes patient-oriented clinical research based upon patients seen in the liver clinic, clinical trials, population-based cohort studies, twin studies with Dr. Daniel O’Connor, and clinical decision making by utilizing meta-analytic approaches. He continues to work in close collaboration with his colleagues at the National Institutes of Health, where he received his clinical and research training in advanced hepatology.

Visit website: https://medschool.ucsd.edu/som/medicine/divisions/gastro/research/labs/fatty-liver/team/Pages/loomba.aspx

 rohit-loomba-4093a1133

 drloomba

See also: Academia University of California, San Diego (UCSD) - Public Research university

Details last updated 04-May-2022

Rohit Loomba News

Liver-fat content and bodyweight reduction with effective use of CB4211

Liver-fat content and bodyweight reduction with effective use of CB4211

GlobeNewswire - 10-Aug-2021

Mitochondrial genome used to potentially treat fatty liver and prevent obesity